What are Geron's total assets?

Geron (GERN) holds $534.1M in total assets, down 5.0% year over year.

How much debt does Geron have?

Geron carries $134.0M in total debt against $229.1M of shareholders' equity, a debt-to-equity ratio of 0.58.

How much cash does Geron have?

Geron holds $48.7M in cash and equivalents.

Can Geron cover its short-term obligations?

Its current ratio is 6.78 — current assets exceed current liabilities.

Where does Geron's balance sheet data come from?

Every line is extracted from Geron's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Geron GERN Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$53.93M+7.4%	$50.19M-28.3%	$70.02M+23.2%	$56.85M+63.0%
Restricted cash	$1.88M+1.1%	$1.86M+66.8%	$1.12M+206%	$364K0.0%
Accounts receivable, net	$140.12M+116%	$64.83M—	$0—	——
Inventories	$337.41M+464%	$59.77M—	$0—	——
Raw materials	$8.93M+82.0%	$4.9M—	——	——
Work in process	$91.97M+206%	$30.09M—	——	——
Finished goods	$15.74M+323%	$3.72M—	——	——
Prepaid expenses and other current assets	$4.61M-8.8%	$5.05M+3.6%	$4.88M+22.2%	$3.99M+194%
Total current assets	$520.27M+6.0%	$490.99M+43.8%	$341.35M+89.4%	$180.25M-3.7%
Property and equipment, net	$884K-32.5%	$1.31M+11.3%	$1.18M+48.4%	$793K+22.0%
Operating lease right-of-use assets	$2.15M-25.3%	$2.88M-19.0%	$3.56M-14.3%	$4.15M-12.3%
Long-term investments	$41.29M-56.3%	$94.52M—	——	——
Available-for-sale securities	$321.65M-23.8%	$422.07M+875%	$43.3M—	——
Total assets	$570.54M-3.9%	$593.78M+50.7%	$394.08M+107%	$190.58M-15.7%
Accounts payable	$11.26M+31.0%	$8.6M+39.5%	$6.16M-39.5%	$10.19M+52.4%
Accrued expenses	$30.5M+33.7%	$22.81M+65.8%	$13.76M+19.3%	$11.53M+42.4%
Current portion of long-term debt	——	$0-100%	$46.89M+124%	$20.95M—
Operating lease liabilities, current	$1M+2.7%	$974K+2.6%	$949K+2.6%	$925K+2.7%
Accrued interest	$3.11M+42.3%	$2.19M—	——	——
Total current liabilities	$111.54M+26.3%	$88.3M-18.3%	$108.07M+40.9%	$76.69M+68.5%
Long-term debt	$119.55M+0.9%	$118.48M+238%	$35.05M+16.0%	$30.21M-39.4%
Operating lease liabilities, non-current	$1.45M-36.2%	$2.27M-24.6%	$3.01M-18.1%	$3.67M-14.0%
Total liabilities	$129.58M-58.7%	$313.46M+115%	$146.13M+32.1%	$110.58M+11.0%
Preferred stock	$0—	$0—	——	——
Common stock	$640K+5.6%	$606K+11.2%	$545K+39.7%	$390K+20.4%
Additional paid-in capital	$2.08B+1.4%	$2.05B+11.2%	$1.84B+23.5%	$1.49B+6.8%
Retained earnings	-$1.86B-4.7%	-$1.77B-10.9%	-$1.6B-13.0%	-$1.41B-11.2%
Accumulated other comprehensive income (loss)	$269K+3.1%	$261K+41.1%	$185K+184%	-$219K-26.6%
Total stockholders' equity	$225.87M-19.4%	$280.32M+13.1%	$247.95M+210%	$80M-36.7%
Total liabilities and stockholders' equity	$570.54M-3.9%	$593.78M+50.7%	$394.08M+107%	$190.58M-15.7%
Available-for-Sale Debt Securities	$280.36M-14.4%	$327.55M—	——	——
Available-for-Sale Debt Securities - Amortized Cost	$321.42M-23.8%	$421.79M—	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)	$0-100%	$1.99M—	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)	$0-100%	$1.99M—	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$49.25M-71.0%	$169.72M—	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)	$49.25M-71.0%	$169.72M—	——	——
Available-for-Sale Debt Securities - Unrealized Loss Position	$54K-71.7%	$191K—	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Fair Value	$0-100%	$1.99M—	——	——
AFS and Trading Securities - Unrealized Loss Position Fair Value	$49.25M-71.3%	$171.72M—	——	——
AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value	$49.25M-71.0%	$169.72M—	——	——
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$79.44M-1.8%	$80.88M+13.7%	$71.14M—	——
Cash, Cash Equivalents, and Marketable Securities	$49.25M-71.3%	$171.72M—	——	——
Debt securities - current	$280.36M-14.4%	$327.55M—	——	——
Finished goods	$15.74M+323%	$3.72M—	——	——
Nontrade Receivables Current	$2.24M-21.5%	$2.85M+72.4%	$1.66M-47.4%	$3.14M+78.3%
Vendor Non-Trade Receivables	$2.24M-21.5%	$2.85M+72.4%	$1.66M-47.4%	$3.14M+78.3%
Net Investment in Lease	$2.15M-25.3%	$2.88M-19.0%	$3.56M-14.3%	$4.15M-12.3%
Deposits and other assets	$5.95M+45.7%	$4.08M-13.2%	$4.7M-12.8%	$5.39M+12.3%
Operating lease right-of-use assets	$2.15M-25.3%	$2.88M-19.0%	$3.56M-14.3%	$4.15M-12.3%
Operating Lease Right-of-Use Assets in Other Assets	$2.15M-25.3%	$2.88M-19.0%	$3.56M-14.3%	$4.15M-12.3%
Accrued Manufacturing Costs	$30.5M+33.7%	$22.81M+65.8%	$13.76M+19.3%	$11.53M+42.4%
Accrued Royalties (Current)	$129.58M—	——	——	——
Other Commercial Liabilities	$51.34M+44.4%	$35.55M-11.8%	$40.31M+21.8%	$33.1M+10.9%
Accrued Liabilities, Current	$51.34M+44.4%	$35.55M-11.8%	$40.31M+21.8%	$33.1M+10.9%
Accrued Vacation Current	$2.58M—	——	——	——
Compensation and benefits	$30.5M+33.7%	$22.81M+65.8%	$13.76M+19.3%	$11.53M+42.4%
Liability related to sale of future royalties	$17.45M-14.4%	$20.37M—	——	——
Professional Service Fees Payable	$881K+85.5%	$475K—	——	——
Restructuring Reserve	$17.03M—	——	——	——
Debt Maturity - 2024	——	——	——	——
Debt Maturity - 2027	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	——	——	——	——
Total debt	$121.99M+0.2%	$121.72M+41.7%	$85.9M+54.1%	$55.75M+1.4%
Total Carrying Value of Debt	——	——	——	——
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss	$0-100%	$1K—	——	——
Common Stock Par Value Per Share	$0.00—	——	——	——
Additional paid-in capital	$2.08B+1.4%	$2.05B+11.2%	$1.84B+23.5%	$1.49B+6.8%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$640K+5.6%	$606K+11.2%	$545K+39.7%	$390K+20.4%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	——	——
Investments - Gross Unrealized Losses	$49.25M-71.3%	$171.72M—	——	——
Preferred Stock Par Value Per Share	$0.00—	——	——	——
Unrealized Gains on Investments	$285K-39.4%	$470K—	——	——
Unrealized Losses on Investments (Before Tax)	$54K-71.7%	$191K—	——	——
Accrued bonuses	$10.34M—	——	——	——
Contract research organization and clinical trial costs	$3.68M-80.6%	$18.97M—	——	——
Manufacturing activities	$38.66M+227%	$11.84M—	——	——
Professional service fees	$881K+85.5%	$475K—	——	——
Accrued Royalties	$129.58M—	——	——	——
Property and equipment, net capitalized	——	——	——	——
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$54K-71.7%	$191K—	——	——
Gross Unrealized Gains	$285K-39.4%	$470K—	——	——
Gross Unrealized Gains	$1K—	$0—	——	——
Cash And Cash Equivalents, Unrealized Losses	$0-100%	$1K—	——	——
Cash and cash equivalents, end of period	$79.44M-1.8%	$80.88M+13.7%	$71.14M—	——
Common stock, par value (in dollars per share)	$0—	——	——	——
Long-term debt, gross	——	——	——	——
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	——	——	——	——
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss	$321.42M-23.8%	$421.79M—	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	$0-100%	$1K—	——	——
Less than 12 months	$49.25M-71.0%	$169.72M—	——	——
12 months or more	$0-100%	$1.99M—	——	——
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	$54K-71.6%	$190K—	——	——
Estimated Fair Value	$321.65M-23.8%	$422.07M—	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss	$54K-71.7%	$191K—	——	——
Debt Securities, Available-for-Sale, Unrealized Loss Position	$49.25M-71.3%	$171.72M—	——	——
Accrued revenue adjustments	$3.49M+199%	$1.17M—	——	——
Noncurrent liability related to sale of future royalties	$112.13M+7.4%	$104.42M—	——	——
2028	——	——	——	——
2029	——	——	——	——
2027	——	——	——	——
Remainder of 2026	——	——	——	——
Thereafter	——	——	——	——
Other accrued liabilities	$1.53M+67.1%	$915K—	——	——
Other Employee Related Liabilities Current	$549K—	——	——	——
Preferred Stock, Par or Stated Value Per Share	$0—	——	——	——
Recorded Unconditional Purchase Obligation	——	——	——	——
Restricted Cash And Cash Equivalents, Gross Unrealized Losses	$0—	$0—	——	——
Gross Unrealized Gains	$0—	$0—	——	——
Restricted marketable debt and other securities (Note 6)	$1.88M+1.1%	$1.86M—	——	——
Restructuring Reserve	$17.03M—	——	——	——
Severance accrual, current	$17.03M—	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Geron.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Geron's total assets?: Geron (GERN) holds $534.1M in total assets, down 5.0% year over year.
How much debt does Geron have?: Geron carries $134.0M in total debt against $229.1M of shareholders' equity, a debt-to-equity ratio of 0.58.
How much cash does Geron have?: Geron holds $48.7M in cash and equivalents.
Can Geron cover its short-term obligations?: Its current ratio is 6.78 — current assets exceed current liabilities.
Where does Geron's balance sheet data come from?: Every line is extracted from Geron's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.